81.84
price down icon3.82%   -3.25
after-market Dopo l'orario di chiusura: 83.00 1.16 +1.42%
loading
Precedente Chiudi:
$85.09
Aprire:
$85.26
Volume 24 ore:
331.09K
Relative Volume:
3.08
Capitalizzazione di mercato:
$3.75B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-5.21%
1M Prestazione:
-37.13%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$80.51
$89.37
Intervallo di 1 settimana:
Value
$80.51
$89.99
Portata 52W:
Value
$80.51
$138.70

Billiontoone Inc Stock (BLLN) Company Profile

Name
Nome
Billiontoone Inc
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
2025-12-09
Name
Ultimi documenti SEC
Name
BLLN's Discussions on Twitter

Confronta BLLN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
BLLN
Billiontoone Inc
81.84 3.89B 0 0 0 0.00
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
579.45 219.21B 43.74B 6.58B 6.11B 17.31
Diagnostics & Research icon
DHR
Danaher Corp
228.92 162.93B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
676.53 54.48B 4.17B 1.03B 940.22M 12.61
Diagnostics & Research icon
A
Agilent Technologies Inc
136.07 39.02B 6.95B 1.30B 1.15B 4.5696
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
225.41 38.78B 15.90B 1.28B 2.21B 7.2842

Billiontoone Inc Stock (BLLN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-12-01 Iniziato BTIG Research Buy
2025-12-01 Iniziato JP Morgan Overweight
2025-12-01 Iniziato Jefferies Hold
2025-12-01 Iniziato Piper Sandler Overweight
2025-12-01 Iniziato Stifel Buy
2025-12-01 Iniziato Wells Fargo Equal Weight
2025-12-01 Iniziato William Blair Outperform
Mostra tutto

Billiontoone Inc Borsa (BLLN) Ultime notizie

pulisher
Dec 31, 2025

Med-tech IPOs shoot for the stars in 2025 - BioWorld MedTech

Dec 31, 2025
pulisher
Dec 31, 2025

BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference - 富途牛牛

Dec 31, 2025
pulisher
Dec 29, 2025

BillionToOne stock in focus before Monday open after Friday jump, JPMorgan conference next - ts2.tech

Dec 29, 2025
pulisher
Dec 28, 2025

BillionToOne (BLLN) Stock Update: Friday Rally, Analyst Price Targets, and the Next Catalysts Before Nasdaq Reopens - ts2.tech

Dec 28, 2025
pulisher
Dec 27, 2025

BillionToOne Stock (NASDAQ: BLLN) News: Weekend Market Wrap, Analyst Targets, and What to Watch Before Monday’s Open - ts2.tech

Dec 27, 2025
pulisher
Dec 27, 2025

BillionToOne Stock (NASDAQ: BLLN) Rises Into the Weekend as Analyst Targets Point Higher — What Investors Need to Know Before Monday - ts2.tech

Dec 27, 2025
pulisher
Dec 26, 2025

Evommune and BillionToOne climb on trading debut - MSN

Dec 26, 2025
pulisher
Dec 25, 2025

BillionToOne (BLLN) Is Down 6.7% After Joining the S&P Total Market IndexWhat's Changed - simplywall.st

Dec 25, 2025
pulisher
Dec 24, 2025

BillionToOne: An Interesting Set-Up Into 2026 - Seeking Alpha

Dec 24, 2025
pulisher
Dec 22, 2025

BillionToOne Stock (NASDAQ: BLLN) News, Forecasts, and Analyst Outlook for December 22, 2025 - ts2.tech

Dec 22, 2025
pulisher
Dec 21, 2025

BillionToOne Adds Genmab CFO Anthony Pagano to Board, Names Him Audit Chair - TipRanks

Dec 21, 2025
pulisher
Dec 17, 2025

Analysts Are Bullish on These Healthcare Stocks: Gilead Sciences (GILD), BillionToOne, Inc. Class A (BLLN) - The Globe and Mail

Dec 17, 2025
pulisher
Dec 16, 2025

BillionToOne’s Earnings Call: Strong Growth and Strategic Outlook - TipRanks

Dec 16, 2025
pulisher
Dec 16, 2025

BillionToOne, Inc. (NASDAQ:BLLN) Q3 2025 earnings call transcript - MSN

Dec 16, 2025
pulisher
Dec 15, 2025

symbol__ Stock Quote Price and Forecast - CNN

Dec 15, 2025
pulisher
Dec 12, 2025

Transcript : BillionToOne, Inc., Q3 2025 Earnings Call, Dec 09, 2025 - marketscreener.com

Dec 12, 2025
pulisher
Dec 12, 2025

November reignites med-tech momentum with $4.7B raised - BioWorld MedTech

Dec 12, 2025
pulisher
Dec 12, 2025

These Bay Area companies are IPO contenders in 2026 - The Business Journals

Dec 12, 2025
pulisher
Dec 12, 2025

BillionToOne, Inc.: Strong Financial Performance and Strategic Market Positioning Drive Buy Rating - TipRanks

Dec 12, 2025
pulisher
Dec 11, 2025

BillionToOne (BLLN) Revenue Surge Tests Bullish Growth Narrative Despite Ongoing EPS Losses - Sahm

Dec 11, 2025
pulisher
Dec 11, 2025

BillionToOne, Inc.: Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating - TipRanks

Dec 11, 2025
pulisher
Dec 10, 2025

BillionToOne, Inc. SEC 10-Q Report - TradingView — Track All Markets

Dec 10, 2025
pulisher
Dec 10, 2025

BillionToOne price target lowered to $145 from $150 at JPMorgan - MSN

Dec 10, 2025
pulisher
Dec 10, 2025

BillionToOne stock rating reiterated at Overweight by Piper Sandler - Investing.com South Africa

Dec 10, 2025
pulisher
Dec 10, 2025

Jim Cramer Says BillionToOne Has a “Fantastic Story” Within the Diagnostics Space - MSN

Dec 10, 2025
pulisher
Dec 10, 2025

BillionToOne Swings To Profit In Q3; Sees Q4 Revenue Soaring Up To 100% - Nasdaq

Dec 10, 2025
pulisher
Dec 10, 2025

BillionToOne’s Strong Growth Potential and Strategic Integration Drive Buy Rating - TipRanks

Dec 10, 2025
pulisher
Dec 10, 2025

BTIG Reiterates 'Buy' Rating for BillionToOne (BLLN) with PT of $160 | BLLN Stock News - GuruFocus

Dec 10, 2025
pulisher
Dec 09, 2025

Earnings call transcript: BillionToOne’s strong Q3 2025 lifts stock 3.19% By Investing.com - Investing.com Nigeria

Dec 09, 2025
pulisher
Dec 09, 2025

Billiontoone Q3 2025 Earnings Call Transcript - MarketBeat

Dec 09, 2025
pulisher
Dec 09, 2025

BillionToOne Q3 2025 presentation slides: Revenue soars 117% as profitability achieved - Investing.com Canada

Dec 09, 2025
pulisher
Dec 09, 2025

Earnings call transcript: BillionToOne’s strong Q3 2025 lifts stock 3.19% - Investing.com

Dec 09, 2025
pulisher
Dec 09, 2025

Earnings call transcript: BillionToOne's strong Q3 2025 lifts stock 3.19% - Investing.com

Dec 09, 2025
pulisher
Dec 09, 2025

BillionToOne appoints Genmab CFO Anthony Pagano to board - Investing.com

Dec 09, 2025
pulisher
Dec 09, 2025

BillionToOne sees Q4 revenue $84M-$90M, consensus $80.14M - TipRanks

Dec 09, 2025
pulisher
Dec 09, 2025

BillionToOne Appoints Anthony Pagano as Audit Chair - TipRanks

Dec 09, 2025
pulisher
Dec 09, 2025

BillionToOne Q3 Swings to Profit, Revenue Rises; Shares Fall After Hours - marketscreener.com

Dec 09, 2025
pulisher
Dec 09, 2025

BillionToOne appoints Genmab CFO Anthony Pagano to board By Investing.com - Investing.com Australia

Dec 09, 2025
pulisher
Dec 09, 2025

BillionToOne reports Q3 EPS 10c, consensus 16c - TipRanks

Dec 09, 2025
pulisher
Dec 09, 2025

BillionToOne Appoints Anthony Pagano to Board and Audit Committee - TradingView — Track All Markets

Dec 09, 2025
pulisher
Dec 09, 2025

BillionToOne sees FY25 revenue $293M-$299M, consensus $288.61M - TipRanks

Dec 09, 2025
pulisher
Dec 09, 2025

(BLLN) BillionToOne Expects Full Year 2025 Revenue Range $293M$299M, vs. FactSet Est of $288.6M - marketscreener.com

Dec 09, 2025
pulisher
Dec 09, 2025

Earnings Flash (BLLN) BillionToOne Posts Q3 EPS $0.10, vs. FactSet Est of $0.14 - marketscreener.com

Dec 09, 2025
pulisher
Dec 09, 2025

BillionToOne, Inc. Reports 117% Revenue Growth and Positive Operating Income in Q3 2025 - Quiver Quantitative

Dec 09, 2025
pulisher
Dec 09, 2025

(BLLN) BillionToOne, Inc. Expects Q4 Revenue Range $84.0M$90.0M - marketscreener.com

Dec 09, 2025
pulisher
Dec 09, 2025

Earnings Flash (BLLN) BillionToOne, Inc. Reports Q3 Revenue $83.5M, vs. FactSet Est of $82.9M - marketscreener.com

Dec 09, 2025
pulisher
Dec 09, 2025

BillionToOne Reports Third Quarter 2025 Results - The Manila Times

Dec 09, 2025
pulisher
Dec 09, 2025

BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair - StreetInsider

Dec 09, 2025

Billiontoone Inc Azioni (BLLN) Dati Finanziari

Non sono disponibili dati finanziari per Billiontoone Inc (BLLN). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$131.16
price down icon 1.20%
diagnostics_research LH
$250.88
price down icon 0.87%
diagnostics_research WAT
$379.83
price down icon 1.08%
diagnostics_research MTD
$1,394.19
price down icon 1.42%
$229.09
price down icon 0.39%
diagnostics_research IQV
$225.41
price down icon 1.00%
Capitalizzazione:     |  Volume (24 ore):